TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 47 filers reported holding TYRA BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,572,737 | -18.2% | 259,458 | +1.2% | 0.00% | – |
| Q2 2023 | $4,366,100 | +17.1% | 256,377 | +10.5% | 0.00% | – |
| Q1 2023 | $3,729,670 | +13.3% | 232,089 | -46.4% | 0.00% | – |
| Q4 2022 | $3,292,716 | +71.9% | 433,252 | +98.8% | 0.00% | – |
| Q3 2022 | $1,916,000 | +25.2% | 217,988 | +1.9% | 0.00% | – |
| Q2 2022 | $1,530,000 | -29.8% | 214,025 | +5.1% | 0.00% | – |
| Q1 2022 | $2,179,000 | +18.2% | 203,680 | +55.5% | 0.00% | – |
| Q4 2021 | $1,843,000 | – | 131,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $75,102,147 | 53.19% |
| Nextech Invest Ltd. | 2,518,582 | $42,891,451 | 14.58% |
| TCG Crossover Management, LLC | 1,989,103 | $33,874,424 | 5.56% |
| Boxer Capital, LLC | 6,448,359 | $109,816 | 5.09% |
| Fairmount Funds Management LLC | 1,416,998 | $24,131,476 | 3.40% |
| RA Capital Management | 7,236,454 | $123,236,812 | 2.33% |
| BVF INC/IL | 2,739,595 | $46,655,303 | 1.30% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $17,507,061 | 1.05% |
| Auour Investments LLC | 85,020 | $1,447,891 | 0.62% |
| Artia Global Partners LP | 45,253 | $770,659 | 0.27% |